News Releases

April 7, 2015

RepliCel Life Sciences Receives TSX Venture Exchange Approval to Extend Warrant Expiry Dates
VANCOUVER, BC – April 7, 2015 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine... Read full article

April 2, 2015

RepliCel Life Sciences Applies to Extend Warrant Expiry Dates
VANCOUVER, BC – April 2, 2015 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine... Read full article

March 23, 2015

RepliCel Meets with Japanese Pharmaceutical and Medical Devices Agency (PMDA)
As part of its Japanese partnering strategy, RepliCel seeks advice of Japanese regulators around its fibroblast platform VANCOUVER, BC – March, 23 – RepliCel... Read full article

March 12, 2015

RepliCel Life Sciences in Japan for Key Industry Meetings
RepliCel activity while in Japan includes co-presenting hair regeneration technology with partner, Shiseido, at the Congress of the Japanese Society for Regenerative Medicine VANCOUVER,... Read full article

February 23, 2015

RepliCel Submits Clinical Trial Application for its Dermatological Clinical Trial
Autologous cell therapy, RCS-01, to be investigated as a potential treatment for aged, UV-damaged skin VANCOUVER, BC – February 23, 2015 – RepliCel Life... Read full article

January 20, 2015

RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
VANCOUVER, BC – January 20, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a clinical stage regenerative medicine company focused on the... Read full article

January 7, 2015

RepliCel Life Sciences to Present at Biotech Showcase 2015
Meetings focused on investors, analysts, and potential partners for RCS-01 and RCT-01 cell therapies VANCOUVER, BC – January 7, 2015 – RepliCel Life Sciences... Read full article

December 22, 2014

Newly Released Peer-Reviewed Publication Further Validates RepliCels Use of Dermal Sheath Cup Cells to Treat Pattern Baldness
VANCOUVER, BC – December 22, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine company focused on the... Read full article

December 2, 2014

RepliCel Life Sciences to Present at World Stem Cell Summit 2014
Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and lead an experts’ roundtable discussion VANCOUVER, BC – December... Read full article

December 1, 2014

RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
Health Canada Issues “No Objection Letter” for RepliCel’s Phase 1/2 Clinical Trial of RCT-01 VANCOUVER, BC – December 1, 2014 – RepliCel Life Sciences... Read full article